Preventive Health

Study reveals socioeconomic barriers to children’s healthcare access

Research published in the Australian Journal of General Practice (AJGP) has revealed mental health and developmental–behavioural issues such as ADHD are the most common paediatric referrals in metropolitan general practices.

But the research also revealed children at higher risk are less likely to get the care they may need.


The role of genomic screening in transforming public health

Dr Jane Tiller is a lawyer, genetic counsellor and public health researcher. She is Ethical, Legal & Social Adviser in Public Health Genomics at Monash University, and a National Health and Medical Research Council Investigator Grant holder. Jane is passionate about the use of genomics to prevent disease, and in delivering equitable access to preventive genetic information at the population level. She is co-lead of DNA Screen, a world-first study piloting the offer of preventive DNA screening to the Australian adult population. DNA Screen has tested over 10,000 young people for genetic high risk of medically actionable conditions such as cancer and heart disease, finding about 2% of participants had genetic high risk. Jane is leading efforts to secure Commonwealth Government funding to expand the DNA Screen program, with the eventual goal of the development of a public health population screening program for disease prevention based on high genetic risk.

South Australia prioritises preventive health

On 28th November 2024, the SA Parliament passed legislation to make preventive health a key part of South Australian health system for the first time, through a new agency aptly named Preventive Health SA.

Preventive Health SA will lead evidence-informed and innovative action to prevent and reduce the burden of non-communicable health conditions and improve health equity across the South Australia population.

Scroll to top